Acadian Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGNT
VC
BFA
PCM
CC
NIMC
EAM
SAM
BIT
Acadian Asset Management's SGNT Position: Q2 2016 in Review
Acadian Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 41,300 shares — an estimated $502K sold.
Acadian Asset Management first reported a position in SGNT in Q3 2013 and held it in 11 quarters. The position peaked at $30.8M in Q4 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.
- Acadian Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- Acadian Asset Management sold 41,300 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $502K.
- Acadian Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 11 quarters.
- Acadian Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $30.8M in Q4 2014.
- 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.
Based on Acadian Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.